Plunkett's Biotech & Genetics Industry Trends & Statistics 2013: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2013

NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Plunkett's Biotech & Genetics Industry Trends & Statistics 2013: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2013

http://www.reportlinker.com/p01054189/Plunketts-Biotech--Genetics-Industry-Trends--Statistics-2013-A-Summary-Version-of-Plunketts-Biotech--Genetics-Industry-Almanac-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

Key Features:

-Industry trends analysis, market data and competitive intelligence-Market forecasts and Industry Statistics-Buyer may register for access to search and export data at Plunkett Research Online

Pages: 77

Statistical Tables Provided: 18

Geographic Focus: Global

A condensed market research report excerpted from Plunkett's Biotech & Genetics Industry Almanac 2013, including forecasts and market estimates, technologies analysis and vital statistical tables. You will gain significant insights that can help you shape your own strategy for business development, product development and investments. -How is the industry evolving? -How is the industry being shaped by new technologies? -How is demand growing in emerging markets and mature economies?-What is the size of the market now and in the future?

Contents, Statistics, Forecasts and Analysis Include:

Major Trends Affecting the Biotech & Genetics Industry

1) The State of the Biotechnology Industry Today

2) A Short History of Biotechnology

3) Ethanol Production Soars, But U.S. Federal Subsidy in Question

4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms

5) From India to Singapore to China, Nations Compete Fiercely in Biotech Development

6) Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns

7) Gene Therapies and Patients' Genetic Profiles Promise a Personalized Approach to Medicine

8) Breakthrough Drugs for Cancer Treatment—Many More Will Follow

9) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues

10) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age

11) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce

12) Breakthrough New Drug Delivery Systems Evolve

13) Stem Cells—Multiple Sources Stem from New Technologies

14) Government Support for Stem Cell Research Evolves

15) Stem Cells—Therapeutic Cloning Techniques Advance

16) Stem Cells—A New Era of Regenerative Medicine Takes Shape

17) Nanotechnology Converges with Biotech

18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise

19) Focus on Vaccines

20) Technology Discussion—Genomics

21) Technology Discussion—Proteomics

22) Technology Discussion—Microarrays

23) Technology Discussion—DNA Chips

24) Technology Discussion—SNPs ("Snips")

25) Technology Discussion—Combinatorial Chemistry

26) Technology Discussion—Synthetic Biology

27) Technology Discussion—Recombinant DNA

28) Technology Discussion—Polymerase Chain Reaction (PCR)

Biotech & Genetics Industry Statistics 1) Biotech Industry Overview 2) The U.S. Drug Discovery & Approval Process 3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 20114) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals:1993-2011 5) Employment in Life & Physical Science Occupations, U.S.: May 2011 6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2011-2013 7) U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012 8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2006-2021 9) U.S. Prescription Drug Expenditures: 1970-2021 10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-201111) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2011-2013 12) Global Area of Biotech Crops by Country: 2011 13) Biologics & Biotechnology R&D, PhRMA Member Companies: 2010 14) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-201115) Sales By Geographic Area, PhRMA Member Companies: 201016) Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 201017) Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function, PhRMA Member Companies: 2010 18) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1975-2011

Table of Contents

PLUNKETT'S BIOTECH & GENETICSINDUSTRY TRENDS & STATISTICS 2013CONTENTSChapter 1: Major Trends Affecting the Biotech & Genetics Industry 11) The State of the Biotechnology Industry Today 22) A Short History of Biotechnology 83) Ethanol Production Soars, But U.S. Federal Subsidy in Question 94) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms 135) From India to Singapore to China, Nations Compete Fiercely in Biotech Development 146) Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns 177) Gene Therapies and Patients' Genetic Profiles Promise a Personalized Approach toMedicine 178) Breakthrough Drugs for Cancer Treatment—Many More Will Follow 219) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues 2210) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age 2511) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce 2712) Breakthrough New Drug Delivery Systems Evolve 2813) Stem Cells—Multiple Sources Stem from New Technologies 2914) Government Support for Stem Cell Research Evolves 3115) Stem Cells—Therapeutic Cloning Techniques Advance 3316) Stem Cells—A New Era of Regenerative Medicine Takes Shape 3417) Nanotechnology Converges with Biotech 3618) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/SelectiveBreeding Offers a Compromise 3719) Focus on Vaccines 4120) Technology Discussion—Genomics 4221) Technology Discussion—Proteomics 4322) Technology Discussion—Microarrays 4423) Technology Discussion—DNA Chips 4424) Technology Discussion—SNPs ("Snips") 4525) Technology Discussion—Combinatorial Chemistry 4526) Technology Discussion—Synthetic Biology 4527) Technology Discussion—Recombinant DNA 4628) Technology Discussion—Polymerase Chain Reaction (PCR) 47Chapter 2: Biotech & Genetics Industry Statistics 48Biotech Industry Overview 49The U.S. Drug Discovery & Approval Process 50U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2011 51U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME)Approvals:1993-2011 52Employment in Life & Physical Science Occupations, U.S.: May 2011 53Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.:Fiscal Years 2011-2013 54U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012 55U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution:2006-2021 56U.S. Prescription Drug Expenditures: 1970-2021 58Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2011 60Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years2011-2013 61Global Area of Biotech Crops by Country: 2011 62Biologics & Biotechnology R&D, PhRMA Member Companies: 2010 63Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2011 64Sales By Geographic Area, PhRMA Member Companies: 2010 65Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2010 66Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function,PhRMA Member Companies: 2010 67Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1975-2011 68

Companies Mentioned

23AndMe Inc

3SBio Inc

4SC AG

Aastrom Biosciences Inc

Abaxis Inc

Abbott Laboratories

Accelrys Inc

Access Pharmaceuticals Inc

Actelion Ltd

Adamis Pharmaceuticals Corporation

Adolor Corp

Advanced Cell Technology Inc

Advanced Life Sciences Holdings Inc

AdvanSource Biomaterials Corporation

Aeolus Pharmaceuticals Inc

AEterna Zentaris Inc

Affymetrix Inc

Agenus Inc

Agilent Technologies Inc

Akorn Inc

Albany Molecular Research Inc

Alcon Inc

Aldagen Inc

Alexion Pharmaceuticals Inc

Alimera Sciences Inc

Alkermes plc

Allergan Inc

Alliance Pharmaceutical Corp

Allos Therapeutics Inc

Alseres Pharmaceuticals Inc

Amarin Corporation plc

Amgen Inc

AmpliPhi Biosciences Corporation

Amylin Pharmaceuticals Inc

Amyris Biotechnologies Inc

Anacor Pharmaceuticals Inc

Angiotech Pharmaceuticals Inc

Anika Therapeutics Inc

APP Pharmaceuticals Inc

Applied Molecular Evolution Inc

Apricus Biosciences Inc

Aptalis Pharma

Aradigm Corporation

Arcadia Biosciences Inc

Arena Pharmaceuticals Inc

Ariad Pharmaceuticals Inc

ArQule Inc

Array BioPharma Inc

Arryx Inc

Astellas Pharma Inc

Astex Pharmaceuticals Inc

AstraZeneca Canada

AstraZeneca plc

Avanir Pharmaceuticals

AVAX Technologies Inc

AVIVA Biosciences Corp

BASF SE

Bausch & Lomb Inc

Baxter International Inc

Bayer AG

Bayer Corp

Bayer Healthcare Pharmaceuticals

BIND Biosciences Inc

Bio Rad Laboratories Inc

Bioanalytical Systems Inc

Biocancell Therapeutics Inc

Biocompatibles International Ltd

BioCryst Pharmaceuticals Inc

Biogen IDEC Inc

Bioheart Inc

BioMarin Pharmaceutical Inc

Biomet Inc

BioNano Genomics

BioReliance Corp

Biosite Inc

BioTime Inc

BrachyTherapy Services Inc

Bristol-Myers Squibb Co

BroadSoft Inc

Burrill & Company

Caliper Life Sciences Inc

Cambrex Corp

Cangene bioPharma Inc

Cangene Corp

Caraco Pharmaceutical Laboratories Ltd

Cardiome Pharma Corp

Cardium Therapeutics Inc

Cegedim SA

Celera Corporation

Celgene Corp

Cell Therapeutics Inc

Cellartis AB

Celldex Therapeutics Inc

Cellular Dynamics International

CEL-SCI Corporation

Celsis International plc

Cephalon Inc

Cepheid

Cerus Corporation

Charles River Laboratories International Inc

Claros Diagnostics Inc

CML Healthcare Inc

Columbia Laboratories Inc

Complete Genomics Inc

Compugen Ltd

Cortex Pharmaceuticals Inc

Covance Inc

Covidien plc

Crucell NV

CSL Limited

Cubist Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc

Curis Inc

CytRx Corporation

Daiichi Sankyo Co Ltd

Dainippon Sumitomo Pharma Co Ltd

deCODE genetics Ltd

Dendreon Corporation

Depomed Inc

diaDexus Inc

Discovery Laboratories Inc

Divi's Laboratories Limited

D-Medical Industries Ltd

Dow AgroSciences LLC

Dr Reddy's Laboratories Limited

DSM Pharmaceutical Products Inc

DuPont (E I du Pont de Nemours & Co)

DuPont Agriculture & Nutrition

Durect Corp

DUSA Pharmaceuticals Inc

Dyax Corp

Eisai Co Ltd

Elan Corp plc

Eli Lilly & Company

Emisphere Technologies Inc

Encorium Group Inc

Endo Health Solutions Inc

EntreMed Inc

Enzo Biochem Inc

Enzon Pharmaceuticals Inc

Epizyme

eResearch Technology Inc

EUSA Pharma (USA) Inc

Evotec AG

Exelixis Inc

Flamel Technologies SA

Forest Laboratories Inc

Galderma Pharma SA

GE Healthcare

Genencor International Inc

Genentech Inc

Generex Biotechnology Corporation

GenMark Diagnostics Inc

Genocea Biosciences

Genomic Health Inc

Gen-Probe Inc

Genta Inc

GenVec Inc

Genzyme Biosurgery

Genzyme Corp

Genzyme Oncology

Geron Corporation

Gilead Sciences Inc

GlaxoSmithKline plc

GTC Biotherapeutics Inc

Harbor BioSciences Inc

Harvard Bioscience Inc

Hemagen Diagnostics Inc

Hemispherx Biopharma Inc

Heska Corp

Hi-Tech Pharmacal Co Inc

Hospira Inc

Human Genome Sciences Inc

Hycor Biomedical Inc

I3 CanReg Inc

ICON plc

Idera Pharmaceuticals Inc

IDEXX Laboratories Inc

Illumina Inc

ImClone Systems Inc

Immtech Pharmaceuticals Inc

ImmuCell Corporation

ImmunoGen Inc

Immunomedics Inc

IMPAX Laboratories Inc

IMS Health Inc

Incyte Corp

Independence Resources plc

Infinity Pharmaceuticals Inc

InSite Vision Inc

Insmed Inc

Institut Straumann AG

Integra Lifesciences Holdings Corp

IntelliPharmaCeutics International Inc

InterMune Inc

International Isotopes Inc

Ion Torrent

Ironwood Pharmaceuticals Inc

Isis Pharmaceuticals Inc

Jazz Pharmaceuticals plc

Johnson & Johnson

Joule Unlimited Technologies

Jubilant Biosys Ltd

Keryx Biopharmaceuticals Inc

KV Pharmaceutical Co

La Jolla Pharmaceutical Company

Lannett Company Inc

Lexicon Pharmaceuticals Inc

Life Technologies Corp

LifeCell Corporation

Lifecore Biomedical Inc

Ligand Pharmaceuticals Inc

Lonza Group Ltd

Lorus Therapeutics Inc

Luminex Corporation

Marina Biotech Inc

Maxygen Inc

Medicines Co (The)

Medicis Pharmaceutical Corp

Medidata Solutions Inc

Medimmune Inc

MEDTOX Scientific Inc

Merck & Co Inc

Merck KGaA

Merck Serono SA

Meridian Bioscience Inc

Metabolix Inc

Metabolon Inc

Millennium Pharmaceuticals Inc

Millipore Corp

Monsanto Co

Mylan Inc

Myriad Genetics Inc

Myriad RBM

Nabi Biopharmaceuticals

NanoBio Corporation

Navidea Biopharmaceuticals Inc

Nektar Therapeutics

Neogen Corporation

Nordion Inc

Novartis AG

Novavax Inc

Noven Pharmaceuticals Inc

Novo-Nordisk AS

Novozymes

NPS Pharmaceuticals Inc

Nycomed

Obagi Medical Products Inc

OncoGenex Pharmaceuticals Inc

Oncothyreon Inc

Onyx Pharmaceuticals Inc

OraSure Technologies Inc

Orchid Cellmark Inc

Ore Holdings Inc

Organogenesis Inc

OSI Pharmaceuticals LLC

Otsuka Holdings Co Ltd

OXiGENE Inc

Pacific Biosciences of California Inc

Pain Therapeutics Inc

Palatin Technologies Inc

Par Pharmaceutical Companies Inc

PAREXEL International Corp

PDL BioPharma

Peregrine Pharmaceuticals Inc

Perrigo Co

Pfizer Inc

Pharmaceutical Product Development Inc

Pharmacyclics Inc

PharmaNet/i3

Pharmathene Inc

Pharmos Corp

Pharsight Corp

Pioneer Hi-Bred International Inc

Polydex Pharmaceuticals Ltd

Poniard Pharmaceuticals Inc

Pozen Inc

PRA International

Progenics Pharmaceuticals Inc

Promega Corp

Protein Polymer Technologies Inc

QIAGEN NV

QLT Inc

Quest Diagnostics Inc

Questcor Pharmaceuticals Inc

Quintiles Transnational Corp

Ranbaxy Laboratories Limited

Raptor Pharmaceutical Corp

Regeneron Pharmaceuticals Inc

Repligen Corporation

Repros Therapeutics Inc

Rigel Pharmaceuticals Inc

Roche Holding Ltd

S&W Seed Co

Salix Pharmaceuticals

Sangamo BioSciences Inc

Sanofi SA

Sarepta Therapeutics Inc

Savient Pharmaceuticals Inc

SciClone Pharmaceuticals Inc

Scios Inc

Seattle Genetics

Sequenom Inc

SeraCare Life Sciences Inc

Shionogi Inc

Shire Canada Inc

Shire plc

Siemens Healthcare Diagnostics

SIGA Technologies Inc

Sigma-Aldrich Corp

Simcere Pharmaceutical Group

SkyePharma plc

Soligenix Inc

Specialty Laboratories Inc

Spectral Diagnostics Inc

Spectrum Pharmaceuticals Inc

Spherix Inc

StemCells Inc

Stiefel Laboratories Inc

Synageva BioPharma Corp

Synbiotics Corp

Syngenta AG

Synovis Life Technologies Inc

Synthetic Genomics Inc

Takeda Pharmaceutical Company Ltd

Tamir Biotechnology Inc

Taro Pharmaceutical Industries

Techne Corp

Telik Inc

Tengion Inc

Teva Parenteral Medicines Inc

Teva Pharmaceutical Industries Ltd

TG Therapeutics Inc

Theragenics Corp

Thermo Fisher Scientific Inc

Thermo Scientific

Titan Pharmaceuticals Inc

TOLMAR Inc

Toyobo Co Ltd

Trinity Biotech plc

Tripos International

Trius Therapeutics Inc

UCB SA

Unigene Laboratories Inc

United Therapeutics Corp

United-Guardian Inc

Urigen Pharmaceuticals Inc

Valeant Pharmaceuticals International

Ventria Bioscience

Verenium Corporation

Vermillion Inc

Vernalis plc

Vertex Pharmaceuticals Inc

ViaCord Inc

Vical Inc

Virbac Corp

ViroPharma Inc

Vivus Inc

Warner Chilcott plc

Watson Pharmaceuticals Inc

Whatman plc

XDX Inc

XenoPort Inc

XOMA Corporation

ZIOPHARM Oncology Inc

Zogenix Inc

ZymoGenetics Inc

To order this report:: Plunkett's Biotech & Genetics Industry Trends & Statistics 2013: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2013

Contact Clare: clare@reportlinker.com

US:(339) 368 6001

Intl:+1 339 368 6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.